Myriad's Shares Rise Following Q4 Results, Upgrade | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Myriad Genetics climbed more than 17 percent today after the firm reported fourth-quarter earnings that beat analysts' consensus estimate, and the company's shares received an upgrade from an investment bank.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.